Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Apr 16, 2021; 13(4): 97-110
Published online Apr 16, 2021. doi: 10.4253/wjge.v13.i4.97
Published online Apr 16, 2021. doi: 10.4253/wjge.v13.i4.97
Variable | LD EGD (n = 25146), n (%) | HD EGD (n = 113281), n (%) | P value | LD colonoscopy (n = 37991), n (%) | HD colonoscopy (n = 194684), n (%) | P value |
Age, mean ± SD | 51.9 ± 21.9 | 58.2 ± 19.2 | < 0.0001 | 56.8 ± 14.5 | 59.7 ± 22.6 | < 0.0001 |
Female gender | 13095 (52.1) | 55617 (49.1) | < 0.0001 | 18548 (48.8) | 89973 (46.2) | < 0.0001 |
Hispanic | 6091 (24.2) | 20479 (18.1) | < 0.0001 | 9052 (23.8) | 22533 (11.6) | < 0.0001 |
White | 19704 (78.4) | 91529 (80.8) | < 0.0001 | 30643 (80.7) | 168539 (86.6) | < 0.0001 |
Black | 2084 (8.3) | 6427 (5.7) | < 0.0001 | 2262 (6.0) | 8605 (4.4) | < 0.0001 |
Asian | 1284 (5.1) | 3985 (3.5) | < 0.0001 | 2213 (5.8) | 5484 (2.8) | < 0.0001 |
Other race | 2025 (8.1) | 9697 (8.6) | < 0.0001 | 3220 (8.5) | 10100 (5.2) | < 0.0001 |
BMI (kg/m2), mean ± SD | 27.8 ± 15.2 | 28.2 ± 19.8 | < 0.0001 | 28.3 ± 19.9 | 28.2 ± 17 | < 0.0001 |
Exam duration (min), mean ± SD | 9 ± 12 | 10 ± 8 | < 0.0001 | 20 ± 24 | 23 ± 23 | < 0.0001 |
Medication dosage, mean ± IQR | ||||||
Fentanyl (mcg) | 45 ± 8.3 | 205.6 ± 11.1 | 47.6 ± 9 | 255.9 ± 15.3 | ||
Meperidine (µg) | 33.9 ± 7.2 | 170.3 ± 10.4 | 45.7 ± 12.3 | 152.8 ± 11.6 | ||
Midazolam (mg) | 1.3 ± 9.4 | 6.3 ± 19.7 | 1.8 ± 17.4 | 8.8 ± 21.2 | ||
Diphenhydramine (mg) | N/A | 25.2 ± 13.5 | N/A | 50.3 ± 11.5 | ||
Personnel managing sedation, n (%) | ||||||
Endoscopist | 11522 (45.8) | 63187 (55.8) | < 0.0001 | 15608 (41.1) | 96376 (49.5) | < 0.0001 |
Anesthesiologist | 13572 (54.0) | 49656 (43.8) | < 0.0001 | 21288 (56.0) | 89120 (45.8) | < 0.0001 |
Other | 9042 (36.0) | 216 (0.19) | < 0.0001 | 1095 (2.9) | 46 (0.02) | < 0.0001 |
Unplanned intubations, n (%) | 132 (0.5) | 239 (0.2) | < 0.0001 | 5 (0.01) | 19 (0.01) | < 0.0001 |
Aborted procedures, n (%) | 5791 (23.0) | 1371 (1.2) | < 0.0001 | 1602 (4.2) | 341 (0.2) | < 0.0001 |
Admission status, n (%) | ||||||
Inpatient | 4936 (19.6) | 12300 (10.9) | < 0.0001 | 1642 (4.3) | 4894 (2.5) | < 0.0001 |
Outpatient | 20204 (80.3) | 100756 (88.9) | < 0.0001 | 36349 (95.7) | 189631 (97.4) | < 0.0001 |
Location of procedure, n (%) | ||||||
Ambulatory surgical center | 14469 (57.5) | 70643 (62.4) | < 0.0001 | 24967 (65.7%) | 137399 (70.6) | < 0.0001 |
Endoscopy suite | 9790 (38.9) | 40263 (35.5) | < 0.0001 | 12735 (33.5) | 56352 (28.9) | < 0.0001 |
Hospital ward | 150 (0.6) | 205 (0.2) | < 0.0001 | 24 (0.06) | 72 (0.04) | < 0.0001 |
ICU | 668 (2.7) | 1678 (1.5) | < 0.0001 | 114 (0.3) | 205 (0.1) | < 0.0001 |
Operating room | 16 (0.1) | 66 (0.06) | < 0.0001 | 4 (0.01) | 18 (0.01) | < 0.0001 |
Other1 | 479 (1.9) | 201 (0.2) | < 0.0001 | 147 (0.4) | 47 (0.02) | < 0.0001 |
Characteristic | Adjusted OR1 (95%CI) | P value |
Age ≥ 50 vs < 50 (yr) | 1.61 (1.57-1.65) | < 0.0001 |
BMI ≥ 25 vs < 25 (kg/m2) | 0.81 (0.77-0.86) | < 0.0001 |
Females (vs males) | 1.14 (1.12-1.16) | < 0.0001 |
African Americans vs Whites | 1.51 (1.46-1.57) | < 0.0001 |
Asians vs Whites | 2.29 (2.19-2.39) | < 0.0001 |
Hispanics vs Whites | 2.06 (2.01-2.10) | < 0.0001 |
Colonoscopy vs EGD | 0.97 (0.95-0.99) | 0.001 |
Outpatient vs inpatient | 0.70 (0.67-0.72) | < 0.0001 |
Completed: No vs yes | 1.18 (1.12-1.24) | < 0.0001 |
ASA ≥ III vs ASA < III | 1.45 (1.41-1.49) | < 0.0001 |
Location: OR vs endoscopy suite | 0.97 (0.95-0.99) | 0.005 |
Location: Other site2 vs endoscopy suite | 1.25 (1.16-1.34) | < 0.0001 |
Duration: ≥ 30-60 vs < 30 (min) | 0.96 (0.93-0.99) | 0.02 |
Duration: > 60 vs < 30 (min) | 0.52 (0.48-0.57) | < 0.0001 |
Characteristic | EGD group adjusted OR1 (95%CI) | P value | Colonoscopy group adjusted OR1 (95%CI) | P value |
Age ≥ 50 vs < 50 (yr) | 2.23 (2.15-2.31) | < 0.0001 | 1.16 (1.13-1.20) | < 0.0001 |
BMI ≥ 25 vs < 25 (kg/m2) | 1.18(1.09-1.28) | < 0.0001 | 0.67 (0.63-0.72) | < 0.0001 |
Females (vs males) | 1.23 (1.19-1.26) | < 0.0001 | 1.08 (1.05-1.10) | < 0.0001 |
African Americans vs Whites | 1.43 (1.35-1.51) | < 0.0001 | 1.54 (1.46-1.62) | < 0.0001 |
Asians vs Whites | 1.73 (1.61-1.86) | < 0.0001 | 2.70 (2.56-2.85) | < 0.0001 |
Hispanics vs Whites | 1.58 (1.53-1.64) | < 0.0001 | 2.49 (2.42-2.56) | < 0.0001 |
Outpatient vs inpatient | 0.59 (0.57-0.62) | < 0.0001 | 0.85 (0.80-0.91) | < 0.0001 |
Completed: No vs yes | 1.01 (0.89-1.14) | 0.89 | 1.22 (1.15-1.29) | < 0.0001 |
ASA ≥ III vs ASA < III | 1.44 (1.39-1.49) | < 0.0001 | 1.44 (1.39-1.50) | < 0.0001 |
Location: OR vs endoscopy suite | 1.10 (1.06-1.14) | < 0.0001 | 0.91 (0.89-0.94) | < 0.0001 |
Location: Other site2 vs endoscopy suite | 1.06 (0.97-1.16) | 0.20 | 1.75 (1.51-2.01) | < 0.0001 |
Duration: ≥ 30-60 vs < 30 (min) | 1.12 (1.07-1.17) | < 0.0001 | 0.81 (0.77-0.85) | < 0.0001 |
Duration: > 60 vs < 30 (min) | 0.35 (0.27-0.45) | < 0.0001 | 0.55 (0.50-0.60) | < 0.0001 |
- Citation: Passi M, Rahman F, Gurram S, Kumar S, Koh C. Identifying who best tolerates moderate sedation: Results from a national database of gastrointestinal endoscopic outcomes. World J Gastrointest Endosc 2021; 13(4): 97-110
- URL: https://www.wjgnet.com/1948-5190/full/v13/i4/97.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i4.97